Screener
CytomX Therapeutics CTMX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's book value per share?
- CytomX Therapeutics (CTMX) reported book value per share of $1.38 in Q2 2026.
- How has CytomX Therapeutics's book value per share changed year-over-year?
- CytomX Therapeutics's book value per share increased by 48.5% year-over-year, from $0.93 to $1.38.
- What is the long-term trend for CytomX Therapeutics's book value per share?
- Over 5 years (2020 to 2025), CytomX Therapeutics's book value per share has grown at a 33.9% compound annual growth rate (CAGR), from -$0.17 to $0.72.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about CytomX Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude